|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 257.92 USD | +0.58% |
|
+1.38% | +12.78% |
| 07-18 | Jarden Adjusts ResMed's Price Target to AU$40.55 from AU$40.54, Keeps at Overweight | MT |
| 07-15 | RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 | MT |
| Capitalization | 37.76B 32.39B 30.18B 28.08B 51.81B 3,252B 57.85B 365B 138B 1,525B 142B 139B 5,604B | P/E ratio 2025 * |
27.8x | P/E ratio 2026 * | 25.4x |
|---|---|---|---|---|---|
| Enterprise value | 37.36B 32.06B 29.87B 27.79B 51.27B 3,218B 57.25B 361B 136B 1,509B 140B 137B 5,546B | EV / Sales 2025 * |
7.29x | EV / Sales 2026 * | 6.57x |
| Free-Float |
76.64% | Yield 2025 * |
0.84% | Yield 2026 * | 0.98% |
More valuation ratios
* Estimated data
More news
Last Transcript: ResMed, Inc.
More recommendations
More press releases
More news
| 1 day | +0.58% | ||
| 1 week | +1.38% | ||
| Current month | -0.03% | ||
| 1 month | +2.81% | ||
| 3 months | +21.14% | ||
| 6 months | +7.57% | ||
| Current year | +12.78% |
| 1 week | 250.18 |  | 260.37 |
| 1 month | 250.18 | | 261.08 |
| Current year | 199.92 | | 263.05 |
| 1 year | 196.43 | | 263.05 |
| 3 years | 132.24 | | 263.05 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 48.99 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 52 | 2013-02-28 |
Brett Sandercock
DFI | Director of Finance/CFO | 58 | 2005-12-31 |
Jim Ellis
CMP | Compliance Officer | - | 2017-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Rich Sulpizio
BRD | Director/Board Member | 75 | 2005-08-24 |
Ron Taylor
BRD | Director/Board Member | 77 | 2004-12-31 |
Mick Farrell
CHM | Chairman | 52 | 2023-01-24 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 1.09% | 21 M€ | +4.92% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.58% | +1.38% | +26.96% | +14.75% | 37.76B | ||
| +0.48% | +1.28% | +13.98% | +141.85% | 186B | ||
| -2.41% | -4.62% | -22.38% | -22.75% | 157B | ||
| -0.97% | +0.43% | +33.63% | +174.83% | 153B | ||
| -2.43% | -7.22% | -21.96% | -25.69% | 136B | ||
| -1.03% | +0.07% | -15.52% | -3.66% | 59.9B | ||
| +0.41% | -2.00% | -11.57% | -24.45% | 44.87B | ||
| +3.75% | +1.92% | -21.23% | -27.32% | 37.96B | ||
| -0.37% | +1.10% | -5.57% | - | 34.78B | ||
| -2.04% | -7.54% | -13.50% | -4.26% | 32.38B | ||
| Average | -0.40% | -1.33% | -3.72% | +24.81% | 87.94B | |
| Weighted average by Cap. | -0.82% | -1.70% | -0.69% | +52.31% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.13B 4.4B 4.1B 3.81B 7.04B 442B 7.86B 49.51B 18.69B 207B 19.23B 18.83B 761B | 5.55B 4.76B 4.44B 4.13B 7.62B 478B 8.51B 53.63B 20.24B 224B 20.83B 20.4B 824B |
| Net income | 1.36B 1.17B 1.09B 1.01B 1.87B 117B 2.09B 13.16B 4.97B 55.01B 5.11B 5B 202B | 1.5B 1.29B 1.2B 1.12B 2.06B 130B 2.31B 14.53B 5.49B 60.76B 5.64B 5.53B 223B |
| Net Debt | -394M -338M -315M -293M -540M -33.92B -603M -3.8B -1.44B -15.9B -1.48B -1.45B -58.46B | -1.27B -1.09B -1.01B -944M -1.74B -109B -1.94B -12.25B -4.63B -51.23B -4.76B -4.66B -188B |
More financial data
* Estimated data
Employees
9,980
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-18 | 257.92 $ | +0.58% | 894,150 |
| 25-07-17 | 256.42 $ | +0.85% | 802,122 |
| 25-07-16 | 254.25 $ | +0.89% | 829,606 |
| 25-07-15 | 252.01 $ | -0.83% | 1,019,805 |
| 25-07-14 | 254.11 $ | -0.11% | 925,027 |
Delayed Quote Nyse, July 18, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
257.92USD
Average target price
269.49USD
Spread / Average Target
+4.49%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RMD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition